Clinical Trial: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

U.S., Nov. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07226999) titled 'A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer' on Nov. 07.

Brief Summary: This study is being done to learn more about a new medicine called PF-08634404 and how well it works when given with chemotherapy to adults with extensive-stage small cell lung cancer (ES-SCLC), a fast-growing type of lung cancer that has spread widely in the body.

To join the study, participants must meet the following conditions:

* Be 18 years or older.

* Have extensive-stage small cell lung cancer confirmed by lab tests.

* Have not received ...